Confocal laser endomicroscopy in ulcerative colitis: a longitudinal study of endomicroscopic changes and response to medical therapy (with videos)

Gastrointestinal Endoscopy

Volumn 84, Issue 2, 2016, Pages 279-286.e1

  Karstensen, John Gásdal ^a   Săftoiu, Adrian ^a,b   Brynskov, Jørn ^a   Hendel, Jakob ^a   Ciocalteu, Adriana ^a,b   Klausen, Pia ^a   Klausen, Tobias Wirenfeldt ^a   Riis, Lene Buhl ^a   Vilmann, Peter ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; FLUORESCEIN; MESALAZINE; VEDOLIZUMAB; FLUORESCENT DYE; GASTROINTESTINAL AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COLONOSCOPE; COLONOSCOPY; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE CRYPT; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; ULCERATIVE COLITIS; AGED; CASE CONTROL STUDY; COLITIS, ULCERATIVE; CONFOCAL MICROSCOPY; INTESTINE MUCOSA; INTRAVITAL MICROSCOPY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLONOSCOPY; FEMALE; FLUORESCEIN; FLUORESCENT DYES; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLIXIMAB; INTESTINAL MUCOSA; INTRAVITAL MICROSCOPY; LONGITUDINAL STUDIES; MALE; MESALAMINE; MICROSCOPY, CONFOCAL; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84963515996     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2016.01.069     Document Type: Article

References (32)

1. 1 Neurath, M.F., Travis, S.P., Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 61 (2012), 1619–1635.
2. 2 Rutgeerts, P., Van Assche, G., Sandborn, W.J., et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology 142 (2012), 1102–1111.
3. 3 Schroeder, K.W., Tremaine, W.J., Ilstrup, D.M., Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 317 (1987), 1625–1629.
4. 4 Colombel, J.F., Rutgeerts, P., Reinisch, W., et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 141 (2011), 1194–1201.
5. 5 Feagan, B.G., Rutgeerts, P., Sands, B.E., et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 369 (2013), 699–710.
6. 6 Buda, A., Hatem, G., Neumann, H., et al. Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: a pilot study. J Crohns Colitis 8 (2014), 304–311.
7. 7 Moussata, D., Goetz, M., Gloeckner, A., et al. Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut 60 (2011), 26–33.
8. 8 Kiesslich, R., Duckworth, C.A., Moussata, D., et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61 (2012), 1146–1153.
9. 9 Salim, S.Y., Soderholm, J.D., Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 17 (2011), 362–381.
10. 10 Atreya, R., Neurath, M.F., IBD pathogenesis in 2014: molecular pathways controlling barrier function in IBD. Nat Rev Gastroenterol Hepatol 12 (2015), 67–68.
11. 11 Neumann, H., Kiesslich, R., Wallace, M.B., et al. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology 139 (2010), 388–392.
12. 12 Wallace, M., Lauwers, G.Y., Chen, Y., et al. Miami classification for probe-based confocal laser endomicroscopy. Endoscopy 43 (2011), 882–891.
13. 13 Li, C.Q., Xie, X.J., Yu, T., et al. Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy. Am J Gastroenterol 105 (2010), 1391–1396.
14. 14 Kiesslich, R., Goetz, M., Lammersdorf, K., et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132 (2007), 874–882.
15. 15 Mace, V., Ahluwalia, A., Coron, E., et al. Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis. J Gastroenterol Hepatol 30:Suppl 1 (2015), 85–92.
16. 16 Liu, J.J., Wong, K., Thiesen, A.L., et al. Increased epithelial gaps in the small intestines of patients with inflammatory bowel disease: density matters. Gastrointest Endosc 73 (2011), 1174–1180.
17. 17 Karstensen, J.G., Saftoiu, A., Brynskov, J., et al. Confocal laser endomicroscopy: a novel method for prediction of relapse in Crohn's disease. Endoscopy 48 (2016), 364–372.
18. 18 Li, C.Q., Liu, J., Ji, R., et al. Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis. BMC Gastroenterol, 14, 2014, 45.
19. 19 Geboes, K., Riddell, R., Ost, A., et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47 (2000), 404–409.
20. 20 Bressenot, A., Salleron, J., Bastien, C., et al. Comparing histological activity indexes in UC. Gut 64 (2015), 1412–1418.
21. 21 Zeger, S.L., Liang, K.Y., Albert, P.S., Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988), 1049–1060.
22. 22 Hanley, J.A., Negassa, A., Edwardes, M.D., et al. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157 (2003), 364–375.
23. 23 Abrams, J.A., Kapel, R.C., Lindberg, G.M., et al. Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 7 (2009), 736–742 quiz 710.
24. 24 Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data. Biometrics 33 (1977), 159–174.
25. 25 Bonett, D.G., Sample size requirements for estimating intraclass correlations with desired precision. Stat Med 21 (2002), 1331–1335.
26. 26 Becker, V., von Delius, S., Bajbouj, M., et al. Intravenous application of fluorescein for confocal laser scanning microscopy: evaluation of contrast dynamics and image quality with increasing injection-to-imaging time. Gastrointest Endosc 68 (2008), 319–323.
27. 27 Turcotte, J.F., Wong, K., Mah, S.J., et al. Increased epithelial gaps in the small intestine are predictive of hospitalization and surgery in patients with inflammatory bowel disease. Clin Transl Gastroenterol, 3, 2012, e19.
28. 28 Iacucci, M.G.X., Panaccione, R., Kaplan, G.G., et al. Colonic confocal laser endomicroscopy findings in patients with primary sclerosing cholangitis. Gastroenterology, 144, 2013, S890.
29. 29 Cartana, T., Saftoiu, A., Gruionu, L.G., et al. Confocal laser endomicroscopy for the morphometric evaluation of microvessels in human colorectal cancer using targeted anti-CD31 antibodies. PLoS One, 7, 2012, e52815.
30. 30 Neumann, H., Vieth, M., Atreya, R., et al. Assessment of Crohn's disease activity by confocal laser endomicroscopy. Inflamm Bowel Dis 18 (2012), 2261–2269.
31. 31 Turcotte, J.F., Kao, D., Mah, S.J., et al. Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos). Gastrointest Endosc 77 (2013), 624–630.
32. 32 Fritscher-Ravens, A., Schuppan, D., Ellrichmann, M., et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 147 (2014), 1012–1020.